BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 4048901)

  • 1. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer].
    Bergoz R
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1024-5. PubMed ID: 4048901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
    Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
    Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
    Chearanai O; Kachintorn U; Plengvanit U
    J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
    Shreeve DR; Klass HJ; Jones PE
    Digestion; 1983; 28(2):96-101. PubMed ID: 6360774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
    Lam SK; Lee NW; Koo J; Hui WM; Fok KH; Ng M
    Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate.
    Miller JP; Hollanders D; Ravenscroft MM; Tweedle DE; Martin DF
    Scand J Gastroenterol Suppl; 1982; 80():39-42. PubMed ID: 6761851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer.
    Vantrappen G; Schuurmans P; Rutgeerts P; Janssens J
    Scand J Gastroenterol Suppl; 1982; 80():23-30. PubMed ID: 6761849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.
    Martin DF; Hollanders D; May SJ; Ravenscroft MM; Tweedle DE; Miller JP
    Lancet; 1981 Jan; 1(8210):7-10. PubMed ID: 6109102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Ardizzone S; Manzionna G; Caruso I; Montrone F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):343-7. PubMed ID: 9690723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cigarette smoking on duodenal ulcer healing and relapse rate.
    Boonyapisit S; Manatsathit S; Kachintorn U; Tanwandee T; Sattawatthamrong Y; Chinapak O
    J Med Assoc Thai; 1994 Nov; 77(11):566-71. PubMed ID: 7759964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
    Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration.
    Dunk AA; Prabhu U; Tobin A; O'Morain C; Mowat NA
    Aliment Pharmacol Ther; 1990 Apr; 4(2):157-62. PubMed ID: 2104081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind trial of cimetidine versus tri-potassium di-citrato bismuthate in chronic duodenal ulceration.
    Ward M; Pollard EJ; Cowen A
    Med J Aust; 1981 Apr; 1(7):363-4. PubMed ID: 7017361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind endoscopic study with De-Nol tablets and cimetidine for duodenal ulcer.
    Bianchi Porro G; Petrillo M; De Nicola C; Lazzaroni M
    Scand J Gastroenterol; 1984 Oct; 19(7):905-8. PubMed ID: 6397848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. A double-blind double-dummy comparative study.
    Moshal MG; Spitaels JM; Khan F
    S Afr Med J; 1981 Sep; 60(11):420-3. PubMed ID: 7025264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and denol.
    Moshal MG; Gregory MA; Pillay C; Spitaels JM
    Scand J Gastroenterol Suppl; 1979; 54():48-51. PubMed ID: 295504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of duodenal ulcer after medical treatment.
    Lane MR; Lee SP
    Lancet; 1988 May; 1(8595):1147-9. PubMed ID: 2896967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.